Cited 34 times in
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.